LABCORP HOLDINGS INC. — Director's Dealing 2017

Sep 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-09-25

Reporting Person: Caveney Brian J (SVP, Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-25	Restricted Stock Unit	$	A	970	Acquired		Common Stock (970)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: The Restricted Stock Units vest fully on 9/25/2020.